RDX-020 program

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameRDX-020 program
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionChloride channel modulators
TargetsChloride channel
Therapy Area/IndicationsAcidosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesArdelyx Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesArdelyx Inc
Active IndicationsN/A
Inactive IndicationsAcidosis

Other Information

ATC CodeN/A
Related LinksN/A